Trial Profile
A phase II, double blind, randomised, dose ranging, safety and efficacy trial of rapid intravenous infusion of zoledronate versus Aredia in breast cancer patients with osteolytic metastases
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Dec 2019
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary) ; Pamidronic acid
- Indications Advanced breast cancer; Cancer metastases
- Focus Therapeutic Use
- 26 Nov 2005 New trial record.